Ticker
ENTACompany Name
ENANTA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cost of Revenue | Cost of Revenue Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 0 | 0% | $ 64.81M |
3/31/2025 | $ 0 | 0% | $ 64.46M |
12/31/2024 | $ 0 | 0% | $ 66.59M |
9/30/2024 | $ 0 | 0% | $ 67.64M |
6/30/2024 | $ 0 | 0% | $ 71.96M |
3/31/2024 | $ 0 | 0% | $ 72.88M |
12/31/2023 | $ 0 | 0% | $ 73.62M |
9/30/2023 | $ 0 | 0% | $ 79.2M |
6/30/2023 | $ 0 | 0% | $ 80.59M |
3/31/2023 | $ 0 | 0% | $ 81.18M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
COGS / Revenues
(=) COGS %
COGS % for ENANTA PHARMACEUTICALS INC is calculated as follows: COGS [ $ 0 ] / Revenues [ $ 122.47M ]
(=) COGS % [ 0% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.81K |
---|---|
min | -50.26% |
max | 172.25% |
average | 46.91% |
median | 50.54% |
std | 31.59% |